权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Identifying niche specific adaptations in Acinetobacter baumannii

鉴定鲍曼不动杆菌的生态位特异性适应

基本信息

批准号：
10449699
负责人：
Mario Feldman
金额：
$ 25.03万
依托单位：
WASHINGTON UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
2022
资助国家：
美国
起止时间：
2022-03-24 至 2024-02-29
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10449699
关键词：
Acinetobacter Acinetobacter baumannii Acinetobacter baumannii pneumonia Adhesions Adopted Alleles Animal Model Animals Antibiotics Attenuated Bacteria Bacterial Adhesins Binding Biology Bladder Blood Catheters Clinical Communities Critical Illness Data Deposition Disease Disease Outbreaks Environment Exhibits Fibrinogen Future General Practitioners Genetic Determinism Genetic Markers Genome Growth Indwelling Catheter Infection Link Lung Lung infections Measures Mediating Microbial Biofilms Modeling Modernization Molecular Chaperones Morbidity - disease rate Multi-Drug Resistance Mus Mutagenesis Operon Organ Osteomyelitis Outcome Pathogenesis Pathogenicity Pathway interactions Patients Phenotype Phylogenetic Analysis Pilum Plasmids Pneumonia Polysaccharides Predisposition Proteins Research Respiratory System Site Source Specific qualifier value Specificity Surface System Testing Therapeutic Intervention Tissues Toxin Triage Urinary tract Urine Virulence Virulence Factors Virulent base carbapenem resistance catheter associated UTI clinically relevant combat comparative genomics experimental study genetic element innovation member mortality mouse model novel novel therapeutic intervention opportunistic pathogen pathogen pathogenic bacteria phenotypic biomarker pneumonia model receptor research and development respiratory soft tissue urinary

项目摘要

Abstract Acinetobacter baumannii (Ab), the most clinically relevant member of the Acinetobacter genus, is an opportunistic pathogen. This bacterium has an alarming predisposition to acquire multi-drug resistance (MDR), and infections associated with MDR-Ab strains are linked to greater morbidity and mortality. Accordingly, carbapenem-resistant Ab recently topped the WHO priority list of bacteria that require research and development of novel therapeutic strategies. Despite the significant worldwide impact of MDR-Ab, when compared to other major MDR pathogens, relatively little is known about Ab pathogenesis. Although Ab most commonly causes pneumonia (40 % of cases), no lung isolates have been used to study Ab pneumonia in animal infection models. Ab also commonly infects other niches such as blood, the urinary tract, and soft-tissues. Classically, Ab strains are regarded as a homogenous group of opportunistic pathogens displaying niche-indiscriminate virulence in critically-ill hosts. As a result, Ab research efforts often extrapolate findings from one Ab strain in a single model of infection to draw conclusions about Ab as a whole. Recent data from my lab has challenged the concept that Ab lacks niche-specificity. Our retrospective analysis indicated that ~20% of Ab clinical isolates are obtained from urinary sources, often from patients with indwelling catheters. Despite this relevant statistic, research on Ab pathogenesis in the context of catheter-associated urinary tract infection (CAUTI) was nonexistent. Thus, my group established the first murine model of Ab CAUTI and employed it to characterize UPAB1, a recent MDR urinary isolate. Employing this model, we have collected evidence that there are genetic determinants in Ab that influence both niche specificity and the infection outcome. In preliminary experiments, we have infected mice with Ab strains from urinary and respiratory sources and identified strains that perform well in one infection model, but poorly in the other. We hypothesize that genetically determined, niche-specific adaptations have occurred in modern Ab strains. In this proposal we will classify Ab strains in niche-specific or generalist groups. Employing comparative genomics, we will determine the genetic elements responsible for niche-specific adaptations and virulence. We expect to identify niche-specific virulence determinants that may be novel targets for innovative antibiotic-independent therapies. Furthermore, the genetic and phenotypic markers identified in this study could help inform the best triage practices and therapeutic interventions to combat potential Ab outbreaks. Finally, we expect to identify modern uropathogenic and respiratory Ab strains that can be broadly adopted by the research community to better investigate two leading manifestations of Ab disease.

摘要